Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Author:

Dangas George D.,Serruys Patrick W.,Kereiakes Dean J.,Hermiller James,Rizvi Ali,Newman William,Sudhir Krishnankutty,Smith Robert S.,Cao Sherry,Theodoropoulos Kleanthis,Cutlip Donald E.,Lansky Alexandra J.,Stone Gregg W.

Funder

Abbott Vascular

Medtronic

Boston Scientific

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial;Serruys;EuroIntervention,2006

2. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial;Stone;JAMA,2008

3. Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents

4. Side-branch occlusion with Xience V everolimus-eluting and Taxus Express2 paclitaxel-eluting stents: 2-year results from the SPIRIT III randomized trial;Lansky;Am J Cardiol,2009

5. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N Engl J Med,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3